Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.

Heart · 2016 · PMC4941167 · PMID 26888572

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with AS also had higher HR for rivaroxaban versus warfarin, which was especially pronounced for major bleeding (this difference did not reach statistical significance; CIs were below and above 1.0).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.